Zura Bio's filing says a press release gave a clinical update on its Phase 2 study, but the filing itself gives no study findings. Without results, it does not change the company's outlook.
The filing points to a press release, but the supplied text does not include patient results, safety findings, or treatment benefits. Without those details, there is no basis to change the view of the study.
Follow Zura Bio Ltd (ZURA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ZURA